GLOBALLY CONNECTED MEDICINAL CANNABIS GROUP
Health House Holdings Limited was founded to pursue opportunities in the burgeoning global medicinal cannabis market.
Since 2014, the Board and founding shareholders of the Company have been pioneers in the Global medicinal cannabis sector establishing a number of publicly-listed companies including AusCann Group, Zelda Therapeutics and CannPal Animal Therapeutics.
Products
Premium Quality Range – Products to view full range of products.
German company making cannabinoid medicine available for different patients and medical conditions in a range of oils.
An EU pharmaceutical licensed company, MGC Pharmaceuticals is driven by the goal to make Phytomedicines available in pharmacies and to patients in need, in the most cost-effective, consistent and efficient manner possible.
CanniMed was the very first producer licensed to sell medical cannabis in Canada.
Strong Global Industry Relationships
This team have established strong relationships across the globe spanning cultivation, research, clinical trials, medical clinics, e-commerce, animal health and recreational sectors as well as in the capital markets of Canada, Australia and Europe/United Kingdom.
Global Cannabis Landscape
Over 60 countries around the world have now legalised medical cannabis.
Timeline: Towards a Legal Medicinal Cannabis Market
DATE
Nov 1996
California
California passes Proposition 215. It becomes the first US state to legalise medicinal cannabis.
DATE
July 2001
Portugal
Portugal decriminalises the use of all drugs.
DATE
July 2001
Canada
Canada passes the Medicinal Marijuana Access Program, which allows clinicians to prescribe medicinal cannabis.
DATE
Nov 2004
Montana
Montana becomes tenth US state to legalise medicinal cannabis.
DATE
Aug 2011
Israel
Israel approves the first government sanctioned cannabis growing operations.
DATE
Nov 2012
Colorado & Washington
Colorado and Washington become the first two states to legalise the recreational use of cannabis.
DATE
May 2013
U.K
UK-based GW Pharmaceuticals, listed on the AIM London market, dual lists on the US NASDAQ.
DATE
April 2014
Canada
Canada introduces the Medical Purposes Regulations, which lets patients access the drug from licensed producers.
DATE
Mar 2015
Italy
The Italian parliament signs a motion to legalise cannabis.
DATE
June 2016
Canopy Growth
Canopy Growth becomes the first cannabis stock to list on the Toronto Stock Exchange.
DATE
Jan 2017
Germany
Germany passes a law legalising the use of cannabis for medical purposes.
DATE
Feb 2017
Israel
Israel announces it will exports of medicinal cannabis.
DATE
Mar 2017
U.K
Sativa becomes the UK’s first medical cannabis investment vehicle to be listed on the NEX Exchange.
DATE
July 2017
Poland
Poland votes in favour of legalising medicinal cannabis.
DATE
Jan 2018
Canada
Canada’s Aurora Cannabis and CanniMed Therapeutics $3.2 billion merger becomes the industry’s biggest M&A deal.
DATE
May 2018
Canada
Canada’s Cronos Group becomes the first cannabis company to list on the US NASDAQ.
DATE
Jul 2018
U.K
UK Home Secretary Sajid Javid changes the classification of medicinal cannabis to Schedule 2.
DATE
Nov 2018
U.K
Medicinal cannabis available on prescription in the UK.
